What is Aethlon Medical Operating Cash Flow per Share?
Aethlon Medical's operating cash flow per share for the
three
months ended in Dec. 2023 was $-0.95.
Aethlon Medical's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-4.34.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 30.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 38.80% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 29.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Aethlon Medical's Operating Cash Flow per Share or its related term are showing as below:
AEMD'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -1.2 Med: 23.7 Max: 51
Current: 30.5
During the past 13 years, Aethlon Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.00% per year. The lowest was -1.20% per year. And the median was 23.70% per year.
AEMD's 3-Year OCF Growth Rate is ranked better than 82.02% of 684
companies
in the Medical Devices & Instruments industry
Industry Median: 3.65
vs AEMD: 30.50
Aethlon Medical Operating Cash Flow per Share Historical Data
The historical data trend for Aethlon Medical's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Aethlon Medical Operating Cash Flow per Share Chart
Competitive Comparison of Aethlon Medical's Operating Cash Flow per Share
For the Medical Devices subindustry, Aethlon Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aethlon Medical's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aethlon Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Aethlon Medical's Price-to-Operating-Cash-Flow falls into.
Aethlon Medical Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Aethlon Medical's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.34
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aethlon Medical Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Aethlon Medical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Aethlon Medical (Aethlon Medical) Business Description
Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AEMD has been successfully added to your 